REFERENCES
- Elner V M, Scales W, Elner S G, et al. Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells. Exp Eye Res 1992; 54: 361–368, [PUBMED], [INFOTRIEVE], [CSA]
- Elner V M, Strieter R M, Elner S G, et al. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 1990; 136: 745–750, [PUBMED], [INFOTRIEVE], [CSA]
- Elner S G, Strieter R M, Elner V M, et al. Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest 1991; 64: 819–825, [PUBMED], [INFOTRIEVE], [CSA]
- Holtkamp G M, van Rossem M, de Vos A F, et al. Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol 1998; 112: 34–43, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kurtz R M, Elner V M, Bian Z M, et al. Dexamethasone and cyclosporin A modulation of human retinal pigment epithelial cell monocyte chemotactic protein-1 and interleukin-8. Invest Ophthalmol Vis Sci 1997; 38: 436–445, [PUBMED], [INFOTRIEVE], [CSA]
- Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121–127, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hoekzema R, Murray P I, van Haren M AC, et al. Analysis of interleukin-6 in endoxin-induced uveitis. Invest Ophthalmol Vis Sci 1991; 32: 88–95, [PUBMED], [INFOTRIEVE], [CSA]
- Murray P I, Hoekzema R, van Haren M AC, et al. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 1990; 31: 917–920, [PUBMED], [INFOTRIEVE], [CSA]
- Kauffmann D JH, van Meurs J C, Mertens D AE, et al. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994; 35: 900–906, [PUBMED], [INFOTRIEVE], [CSA]
- Verma M J, Lloyd A, Rager H, et al. Chemokines in acute anterior uveitis. Curr Eye Res 1997; 16: 1202–1208, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mo J S, Matsukawa A, Ohkawara S, Yoshinaga M. Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Exp Eye Res 1999; 68: 333–340, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dunn K C, Aotaki-Keen A E, Putkey F R, et al. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 1996; 62: 155–169, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nakamura N, Hayasaka S, Zhang X Y, et al. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor κ B binding activities induced by interleukin-1β in human retinal pigment epithelial cell line. Exp Eye Res 2003; 77: 195–202, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cui H S, Hayasaka S, Zhang X Y, et al. Effect of α -melanocyte-stimulating hormone on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line. Ophthalmic Res, (in press)[CSA]
- Delgado M, Munoz-Elias E J, Kan Y, et al. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor α transcriptional activation by regulating nuclear factor-κB and cAMP response element-binding protein/c-Jun. J Biol Chem 1998; 273: 31427–31436, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Delgado M, Martinez C, Pozo D, et al. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-α and IL-6. J Immunol 1999; 162: 1200–1205, [PUBMED], [INFOTRIEVE], [CSA]
- Delgado M, Pozo D, Martinez C, et al. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies. J Immunol 1999; 162: 2358–2367, [PUBMED], [INFOTRIEVE], [CSA]
- Leceta J, Gomariz R P, Martinez C, et al. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP. Ann N Y Acad Sci 2000; 921: 92–102, [PUBMED], [INFOTRIEVE], [CSA]
- Gomariz R, Leceta J, Martinez C, et al. Anti-inflammatory actions of VIP/PACAP. role in endotoxemia. Ann N Y Acad Sci 2000; 921: 284–288, [PUBMED], [INFOTRIEVE], [CSA]
- Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-κB-dependent gene activation at multiple levels in the human monocytic cell line THP-1. J Biol Chem 2001; 276: 369–380, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Delgado M, Ganea D. Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo. J Immunol 2001; 167: 966–975, [PUBMED], [INFOTRIEVE], [CSA]
- Delgado M. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit CBP-NF-kB interaction in activated microglia. Biochem Biophys Res Common 2002; 297: 1181–1185, [CSA], [CROSSREF]
- Delgado M, Leceta J, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J Leukoc Biol 2003; 73: 155–164, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Delgado M, Abad C, Martinez C, et al. PACAP in immunity and inflammation. Ann N Y Acad Sci 2003; 992: 141–157, [PUBMED], [INFOTRIEVE], [CSA]
- Harmar A J, Arimura A, Gozes I, et al. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 1998; 50: 265–270, [PUBMED], [INFOTRIEVE], [CSA]
- Vaudry D, Gonzalez B J, Basille M, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000; 52: 269–324, [PUBMED], [INFOTRIEVE], [CSA]
- Mazzocchi G, Malendowicz L K, Rebuffat P, et al. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland. J Clin Endocrinol Metab 2002; 87: 2575–2580, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nilsson S FE, de Neef P, Robberecht P, Christophe J. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. Exp Eye Res 1994; 58: 459–467, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Onali P, Olianas M. PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species. Brain Res 1994; 641: 132–134, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Olianas M C, Ennas M G, Lampis G, Onali P. Presence of pituitary adenylate cyclase-activating polypeptide receptors in Y-79 human retinoblastoma cells. J Neurochem 1996; 67: 1293–1300, [PUBMED], [INFOTRIEVE], [CSA]
- Olianas M C, Ingianni A, Sogos V, Onali P. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors and PACAP in human fetal retinal. J Neurochem 1997; 69: 1213–1218, [PUBMED], [INFOTRIEVE], [CSA]
- Izumi S, Seki T, Shioda S, et al. Ultrastructural localization of PACAP immunoreactivity in the rat retina. Ann N Y Acad Sci 2000; 921: 317–320, [PUBMED], [INFOTRIEVE], [CSA]
- Silveira M S, Costa M R, Bozza M, Linden R. Pituitary adenylyl cyclase-activating polypeptide prevents induced cell death in retinal tissue through activation of cyclic AMP-dependent protein kinase. J Biol Chem 2002; 277: 16075–16080, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Morio H, Tatsuno I, Hirai A, et al. Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity. Brain Res 1996; 741: 82–88, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shoge K, Mishima H K, Saitoh T, et al. Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons. Brain Res 1999; 839: 66–73, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Said S I, Dickman K, Dey R D, et al. Glutamate toxicity in the lung and neuronal cells: prevention or attenuation by VIP and PACAP. Ann N Y Acad Sci 1998; 865: 226–237, [PUBMED], [INFOTRIEVE], [CSA]
- Uchida D, Arimura A, Somogyvari-Vigh A, et al. Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res 1996; 736: 280–286, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gutierrez-Canas I, Rodriguez-Henche N, Bolanos O, et al. VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal. Br J Pharmacol 2003; 139: 1050–1058, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]